Sjs Investment Consulting Inc. Summit Therapeutics Inc. Transaction History
Sjs Investment Consulting Inc.
- $567 Million
- Q2 2025
A detailed history of Sjs Investment Consulting Inc. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 7 shares of SMMT stock, worth $179. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7
Previous 13
46.15%
Holding current value
$179
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SMMT
# of Institutions
248Shares Held
84.1MCall Options Held
1.76MPut Options Held
2.43M-
Baker Bros. Advisors LP New York, NY24.4MShares$627 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.67MShares$223 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$203 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$168 Million0.02% of portfolio
-
State Street Corp Boston, MA4.85MShares$125 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $5.17B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...